WHO ICTRP trial

Investigating the effect of azithromycin on gullet function in patients with…

ISRCTN16059833 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting

Key facts

Trial ID ISRCTN16059833
Public title Investigating the effect of azithromycin on gullet function in patients with long-term respiratory disease
Scientific title Exploring the effect of azithromycin on oesophageal motility and respiratory symptoms in patients with chronic respiratory disease: a prospective observational study
Primary sponsor Hull University Teaching Hospitals NHS Trust
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Recruiting
Study type Interventional
Phase Not Applicable
Countries England;United Kingdom
Conditions Ashtma, cough, lung fibrosis, COPD Respiratory
Interventions All patients who are being started on azithromycin as part of routine clinical care will be investigated with high-resolution oesophageal manometry prior to the commencement of azithromycin. All patients will then receive 1 month of…
Registration date Dec 16, 2022
Target size 30
Secondary IDs Nil known;NCT05469555;IRAS 1006318
Registry page isrctn.com

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations